In case anyone was wondering, it’s never good to be identified as a “middleman.” That’s the label being applied to pharmacy benefits managers who are being blamed for jacking up pharmaceutical prices through opaque agreements with pharmaceutical manufacturers and insurers, which allow the PBMs to negotiate substantial discounts without passing the savings along to […]
By Olivier Kessler, courtesy of ECAEF Chances are that the current stock market drama will go down in the history books as a “corona crash”. Focusing on the trigger, however, would overlook something essential. In retrospect, the complex and opaque developments in history are often reduced to a few specific events. This corresponds to […]
By Rebecca Christie, courtesy of the Bruegel Institute Suddenly central banks are in the middle of the climate-policy debate and it always seems to zoom in on one question: Should they stop buying “brown” bonds? Either yes, and the traditional inflation-fighting mandate goes out the window, or no and the central bank is leaving […]